Collplant to present at the international conference on biofabrication 2022 in tuscany, italy

Rehovot, israel , sept. 19, 2022 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the company will make a presentation on "recombinant human collagen-based bioinks for biofabrication and modeling applications" at the international conference on biofabrication on september 28 th.
CLGN Ratings Summary
CLGN Quant Ranking